Processa Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Processa Pharmaceuticals, Inc. (PCSA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-18
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.10%.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2015 was 7.20%, a 111.76% increase from fiscal 2014.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2014 was 3.40%, a 0.00% change from fiscal 2013.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2013 was 3.40%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2024-12-31 | -0.10% 10-K · filed 2026-03-18 |
| 2015-12-31 | 7.20% 10-K · filed 2017-06-19 |
| 2014-12-31 | 3.40% 10-K · filed 2017-06-19 |
| 2013-12-31 | 3.40% 10-K · filed 2015-04-14 |
| 2012-12-31 | -3.10% 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |